Case Studies

More than 80% of our clients sell their products primarily outside of their home market. We understand the challenges involved in such a strategy, and provide international intellectual property support to increase the benefits and reduce the drawbacks of a multi-country operating and sales strategy. 

We invite you to read some of our latest case studies that prove our results-oriented and practical approach to IP solutions.

Selecting a Manufacturing Location
A case study on freedom to operate for manufacturing an antibody.
The client had developed a therapeutic antibody, suitable for human administration, but needed to select a manufacturing location. Several non-expired patents meant that manufacturing was not possible in the US.

Planting the Seeds of a Great IP Portfolio
A case study on international planning - even before the first patent application is filed.
The client – a newly formed medical device start-up company – wished to file its first patent application but had not yet decided in which country or countries to market its first product.


Finding Your IP Niche in a Crowded Field
A case study on developing an IP portfolio that is both a sword and a shield.
The client – a mature medical device company – competed in a crowded field; many of its competitors had filed for or obtained patents covering critical aspects of the technology in this field.



GAI helped Compugen develop a cost-effective IP strategy for therapeutic proteins, including timing, construction of claims and international patent filings. The team was knowledgeable in therapeutic protein IP, anticipated our needs, and provided what was needed for a strong IP strategy.
— Jeanne Bernstein, Compugen Patent Attorney
Icecure Medical turns to GAI to act as our patent agent, strategically constructing and reviewing our product patents and comparing them to the patents of the competition. They also provide valuable assistance in helping us with freedom-to-operate issues.
— Nir Berzak, CTO of Icecure Medical Ltd.
GAI provided Dexcel with patent advice on freedom-to-operate issues in a number of countries, including the United States and Europe. We frequently tap into GAI’s pharmaceutical and intellectual property expertise.
— Shirly Weiser, Patent attorney for Dexcel Ltd./Dexcel Pharma Technologies Ltd.
GAI was instrumental in fulfilling IPU Industries licensing agreements with an external research institution while protecting our own intellectual property. We will continue to call on them for assistance with other IP needs.
— IPU Industries, Ltd.